A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

计划入组 57 人 · 首次发布于 2021 年 3 月 8 日

Efficacy of Islet Re-transplantation After Failure of Beta-cell Replacement

计划入组 20 人 · 首次发布于 2026 年 6 月 24 日

Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation

计划入组 606 人 · 首次发布于 2026 年 7 月 23 日

Islet cell replacement therapy (Sernova)

Islet cell replacement therapy (Kadimastem)

ALT-formulated hormone replacement therapies

BIONTECH CELL & GENE THERAPIES GMBH

Sweden

COLORADO JOINT REPLACEMENT

United States

OS Therapies

United States

Breakthrough T1D Publishes Clinical Trial Roadmap for Next-Generation Beta Cell Replacement Therapies

Pluristyx Secures $1.4M from Breakthrough T1D to Develop Universal Immune-Cloaked Cell Line for Type 1 Diabetes Therapies

Vertex Halts VX-264 Diabetes Treatment After Phase 1/2 Trial Fails to Meet Efficacy Endpoint